Comparative diffusion assay to assess efficacy of topical antimicrobial agents against Pseudomonas aeruginosa in

Fabien Aujoulat1, Françoise Lebreton, Sara Romano

  • 1UMR5119, Unité de Bactériologie, Faculté de Pharmacie, Université Montpellier 1, 15 Avenue Charles Flahault, Montpellier Cedex 5, France.

Abstract

Insights

A multiresistant Pseudomonas aeruginosa clone caused infections in burn patients. This clone showed reduced susceptibility to silver sulphadiazine, highlighting the need for routine antimicrobial susceptibility testing in burn care.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Burn Care

Background:

  • Nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa pose a significant threat to severely burned patients.
  • Pseudomonas aeruginosa outbreaks are a concern in burn units, necessitating effective antimicrobial strategies.
  • Current practices often lack in vitro testing for topical antimicrobial efficacy in burns management.

Purpose of the Study:

  • To investigate the antimicrobial susceptibility of a multiresistant Pseudomonas aeruginosa clone isolated from burn patients.
  • To evaluate the efficacy of silver sulphadiazine and other topical antimicrobials against this clone.
  • To develop and validate an optimized diffusion assay for comparative antimicrobial susceptibility testing.

Main Methods:

  • Characterization of the P. aeruginosa clone using ERIC sequence-based PCR.
  • Susceptibility testing of the clone against silver sulphadiazine and other topical antimicrobials.
  • Development and application of an optimized diffusion assay for strain comparison.

Main Results:

  • A multiresistant P. aeruginosa clone was identified, colonizing or infecting 26 patients over two years.
  • The resident clone exhibited lower susceptibility to silver sulphadiazine and cerium silver sulphadiazine compared to other strains.
  • The optimized diffusion assay successfully differentiated the susceptibility profiles of P. aeruginosa strains.

Conclusions:

  • The developed diffusion assay can detect variations in antimicrobial susceptibility among P. aeruginosa strains.
  • This method holds potential for semi-routine implementation in medical microbiology laboratories.
  • Improved susceptibility testing could enhance the management of infections in burn patients.